Douglas Carlyle Cameron is an American engineer, inventor, and investor. He is a senior managing director for the U.S.-China Green Fund. He is on the board of the Foundation for Food and Agriculture Research and is a technical and business advisor to organizations including the VTT, and the Center for Bioenergy Innovation.
In December 1986, Cameron joined the Department of Chemical Engineering at the University of Wisconsin—Madison, as an assistant professor and advanced to full professor. The focus of his research was metabolic engineering and industrial microbiology. One of his first projects was the engineering of the microbial pathway for 1,3-propanediol in Escherichia coli. This work was an early step in a process that was eventually commercialized by DuPont and Tate & Lyle. He is also the inventor of a process for the microbial production of 3-hydroxypropionic acid, which provides a bio-based route to industrial chemicals such as acrylic acid. In 1996 he did a sabbatical at the ETH Zurich in the laboratory of James E. Bailey. In 1998 he took a leave of absence to start the Biotechnology Development Center at Cargill, Inc. in Minneapolis. In 2000 he officially left the University of Wisconsin. Cameron was at Cargill, Inc. from 1998 to 2006, where he was Director of Biotechnology and chief scientist. While at Cargill he worked closely with NatureWorks on the development of a low-pH process for lactic acid as a feedstock for polylactic acid. He and his team also worked with Cargill Ventures on deal-sourcing and due-diligence. In June 2006, Cameron moved from Cargill to join the newly formed Silicon Valleyventure capital firm, Khosla Ventures, as chief scientific officer. In 2008, Cameron returned to the Midwest to help Piper Jaffray build and grow its clean tech investment business. In 2010 he left Piper Jaffray to start Alberti Advisors, a technology and financial consulting business, and to begin raising a clean tech venture fund. In 2011, Cameron and his partner, Tom Erickson, announced the formation of First Green Partners, a venture capital fund focused on early-stage investments in green technologies and environmentally-sound uses of fossil resources such as natural gas, backed by Warburg Pincus. The fund has two remaining portfolio companies, Trelys and Monolith Materials. Cameron is on the board of Trelys. In 2017, Cameron joined the U.S.-China Green Fund, a China-based investment firm focused on addressing environmental problems in China. The firm does private equity and venture investments in both China and the West. The U.S. office is in Chicago.
Awards and Honors
Raphael Katzen Award, Society for Industrial Microbiology, 2009. Fellow, Class of 2008, American Society for the Advancement of Science. Featured profile, Nature Biotechnology, November 2007. Fellow, Society of Industrial Microbiology, 2003. College of Fellows, Class of 2001, American Institute of Medical and Biological Engineering.
U.S. Patents
Polypeptides and biosynthetic pathways for the production of monatin and its precursors, U.S. Patent 9,034,610.
Polypeptides and biosynthetic pathways for the production of monatin and its precursors, U.S. Patent 8,435,765.
Polypeptides and biosynthetic pathways for the production of monatin and its precursors, U.S. Patent 8,372,989.
Production of monatin and monatin precursors, U.S. Patent 8,206,955.
Polypeptides and biosynthetic pathways for the production of monatin and its precursors. U.S. Patent 7,572,607.
Production of 3-hydroxypropionic acid in recombinant organisms, U.S. Patent 6,852,517.
Microbial production of 1,2-propanediol from sugar, U.S. Patent 6,303,352.
Microbial production of 1,2-propanediol from sugar, U.S. Patent 6,087,140.
Novel glycerol phosphatase with stereo-specific activity. U.S. Patent 5,733,749.
Polysaccharide composition and process for preparing same. U.S. Patent 5,288,618.
Galactomannan polysaccharide producing organism. U.S. Patent 5,130,249.
Publications
Romich, M.S., D.C. Cameron, and M.R. Etzel. 1995. Three methods for large scale preservation of a microbial inoculum for bioremediation, in Bioaugementation for Site Remediation, R.E. Hinchee, J. Fredrickson and B.C. Alleman, Battelle Press, Columbus, MD.